HOME >> BIOLOGY >> NEWS
Protein controls acid in cells by direct detection of volume changes, study finds

DALLAS July 5, 2004 A protein responsible for regulating acid levels within cells and pumping out acid accumulated in cardiac cells after a heart attack activates in direct response to changes in a cell's volume, according to a new study by researchers at UT Southwestern Medical Center at Dallas.

Their findings show that the protein NHE1, which is found in the membranes of nearly all cells and is especially active in cancer cells, is regulated by the stretch and pull of the membrane as a cell changes volume. The study appears in the Proceedings of the National Academy of Sciences and is available online.

NHE1, which is called a transporter protein, oscillates its shape rapidly in a cell's membrane. This allows sodium from the outside to come in and protons positively charged particles from inside the cell to escape and lower the cell's acidity. The fewer protons in a cell, the less acidic it is.

"The acidity in the cell is a huge signal for the cell," said Dr. Donald Hilgemann, professor of physiology at UT Southwestern and senior author of the study. "The control of acidity regulates cell growth and proliferation."

Hormones and many other signals that control cell growth and proliferation act on NHE1, he said.

"Our study shows that as cell volume increases, this transporter turns off. If volume decreases, it turns on by directly sensing mechanical changes in the membrane," continued Dr. Hilgemann.

The NHE1 transporter is a protein of much interest to drug developers investigating ways to prevent cell death, which often accompanies heart attacks and strokes. In ischemia, where the blood supply is cut off to cardiac cells or brain cells, cells become very acidic. As the body's normal metabolism gets going again, the NHE1 system starts pumping out the accumulated acid, exchanging the acid for sodium.

"It's such an active system that you can overload the cell with sodium," Dr. Hilgemann said. "Too much sod
'"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
5-Jul-2004


Page: 1 2 3

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein believed to control formation of memory identified by Scripps & UCSD scientists
9. Protein stops blood-vessel growth, holds promise as cancer therapy
10. Proteins transform DNA into molecular velcro
11. Protein engineered to detect nerve gas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
(Date:6/25/2020)... Mass. (PRWEB) , ... June 24, 2020 , ... ... of cloud-based enterprise software and software-driven clinical data services that accelerate drug development, ... for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... solutions to aid in the early detection and prevention of high-burden diseases, and ... enable US-based hospitals and healthcare organizations to utilize existing data in order to ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... announced that the launch of a new clinical diagnostics immuno-oncology service, ... tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for ... of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at ...
Breaking Biology Technology:
Cached News: